Medline Industries, a private manufacturer and distributor of medical products, is now home to New York’s largest rooftop solar project at its Montgomery distribution center, according to a July 20 news release.
Medtronic recalled 348,616 implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators because they might fail to deliver energy when high voltage therapy is needed, the FDA said July 18.
Nearly 8,000 cardiac panel blood tests have been recalled after 41 reports of inaccurate test results that pose the risk of missing a heart attack diagnosis, the FDA said July 17.
Researchers from NYU Langone Health and University of New York, both based in New York City, found discrepancies in the marketing of artificial intelligence and machine learning-enabled medical devices compared with FDA approval summaries.
In 2021, Dallas-based Tenet Healthcare, parent organization of United Surgical Partners International, renewed its longtime supply partnership with national group purchasing organization HealthTrust.
Health systems that are not prepared for “supply shocks” can face reputational and financial losses and quality care issues, according to a July 11 article from McKinsey.
Megadyne, a medical device company owned by Johnson & Johnson’s Ethicon division, recalled 21,000 electrosurgical pads after receiving 63 reports of burn injuries, the FDA said July 11.